Congress created the 340B drug discount program in 1992 with a simple premise: allow hospitals and federal grantees serving a ...

The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...

Despite dramatic expansion over the past 34 years, many rural and underserved hospitals continue to face significant ...

After federal judges blocked HHS’ 340B rebate pilot program from taking effect Jan. 1, HHS is discussing whether to reconsider the drug manufacturers’ plans, according to court documents. On Jan. 7, ...

The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...

Last month, a federal court in Maine halted the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program in its tracks — a ...

Competing policy efforts to lower drug prices could muddy the waters of drug pricing and leave patients unable to afford their prescription medications. Drug companies are essentially forced to abide ...

Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...

Tax-exempt hospitals in Minnesota that have raked in large sums of revenue from a government safety net program spent tens of ...